One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v122.21.4382.4382
Copy DOI Journal: Blood |  Publication Date: Nov 15, 2013 |
 Citations: 20 |
Affiliation: Fred Hutch Cancer Center, City Of Hope National Medical Center, Loyola University Medical Center, Mayo Clinic, University of Miami, BC Cancer Agency, University Hospital Cologne, Seagen (United States), Millennium Engineering and Integration (United States), The University of Texas MD Anderson Cancer CenterThree-Year Follow-Up Data and Characterization Of Long-Term Remissions From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Hodgkin Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
